These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27299584)

  • 21. Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis.
    Chiriaco M; Farinelli G; Capo V; Zonari E; Scaramuzza S; Di Matteo G; Sergi LS; Migliavacca M; Hernandez RJ; Bombelli F; Giorda E; Kajaste-Rudnitski A; Trono D; Grez M; Rossi P; Finocchi A; Naldini L; Gentner B; Aiuti A
    Mol Ther; 2014 Aug; 22(8):1472-1483. PubMed ID: 24869932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent topics and advanced therapies in chronic granulomatous disease.
    Nunoi H; Nakamura H; Nishimura T; Matsukura M
    Hum Cell; 2023 Mar; 36(2):515-527. PubMed ID: 36534309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in chronic granulomatous disease.
    Goldblatt D
    J Infect; 2014 Nov; 69 Suppl 1():S32-5. PubMed ID: 25264161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modern management of chronic granulomatous disease.
    Seger RA
    Br J Haematol; 2008 Feb; 140(3):255-66. PubMed ID: 18217895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lentiviral Gene Therapy of Chronic Granulomatous Disease: Functional Assessment of Universal and Tissue-Specific Promoters.
    Yuan H; Wu X; Liu H; Chang LJ
    Hum Gene Ther; 2023 Jan; 34(1-2):19-29. PubMed ID: 36274229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells.
    Brault J; Vaganay G; Le Roy A; Lenormand JL; Cortes S; Stasia MJ
    Int J Nanomedicine; 2017; 12():2161-2177. PubMed ID: 28356734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in treating chronic granulomatous disease.
    Gennery AR
    Br J Haematol; 2021 Jan; 192(2):251-264. PubMed ID: 32643199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematopoietic Cell Transplantation for Chronic Granulomatous Disease in Japan.
    Yanagimachi M; Kato K; Iguchi A; Sasaki K; Kiyotani C; Koh K; Koike T; Sano H; Shigemura T; Muramatsu H; Okada K; Inoue M; Tabuchi K; Nishimura T; Mizukami T; Nunoi H; Imai K; Kobayashi M; Morio T
    Front Immunol; 2020; 11():1617. PubMed ID: 32849547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease.
    Dinauer MC; Gifford MA; Pech N; Li LL; Emshwiller P
    Blood; 2001 Jun; 97(12):3738-45. PubMed ID: 11389011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics and immunopathology of chronic granulomatous disease.
    Stasia MJ; Li XJ
    Semin Immunopathol; 2008 Jul; 30(3):209-35. PubMed ID: 18509647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dramatic Improvement in the Multifocal Positron Emission Tomography Findings of a Young Adult with Chronic Granulomatous Disease Following Allogeneic Hematopoietic Stem Cell Transplantation.
    Shigemura T; Nakazawa Y; Hirabayashi K; Kobayashi N; Sakashita K; Agematsu K; Koike K
    J Clin Immunol; 2015 Jan; 35(1):84-6. PubMed ID: 25367170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lentiviral gene therapy for X-linked chronic granulomatous disease.
    Kohn DB; Booth C; Kang EM; Pai SY; Shaw KL; Santilli G; Armant M; Buckland KF; Choi U; De Ravin SS; Dorsey MJ; Kuo CY; Leon-Rico D; Rivat C; Izotova N; Gilmour K; Snell K; Dip JX; Darwish J; Morris EC; Terrazas D; Wang LD; Bauser CA; Paprotka T; Kuhns DB; Gregg J; Raymond HE; Everett JK; Honnet G; Biasco L; Newburger PE; Bushman FD; Grez M; Gaspar HB; Williams DA; Malech HL; Galy A; Thrasher AJ;
    Nat Med; 2020 Feb; 26(2):200-206. PubMed ID: 31988463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simian immunodeficiency virus lentivector corrects human X-linked chronic granulomatous disease in the NOD/SCID mouse xenograft.
    Naumann N; De Ravin SS; Choi U; Moayeri M; Whiting-Theobald N; Linton GF; Ikeda Y; Malech HL
    Gene Ther; 2007 Nov; 14(21):1513-24. PubMed ID: 17728796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary manifestations of chronic granulomatous disease.
    Mahdaviani SA; Mohajerani SA; Rezaei N; Casanova JL; Mansouri SD; Velayati AA
    Expert Rev Clin Immunol; 2013 Feb; 9(2):153-60. PubMed ID: 23390946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous disease.
    De Ravin SS; Brault J; Meis RJ; Li L; Theobald N; Bonifacino AC; Lei H; Liu TQ; Koontz S; Corsino C; Zarakas MA; Desai JV; Clark AB; Choi U; Metzger ME; West K; Highfill SL; Kang E; Kuhns DB; Lionakis MS; Stroncek DF; Dunbar CE; Tisdale JF; Donahue RE; Dahl GA; Malech HL
    Blood Adv; 2020 Dec; 4(23):5976-5987. PubMed ID: 33284949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful immune reconstitution by means of hematopoietic stem cell transplantation in a Colombian patient with chronic granulomatous disease.
    Rocha YC; López JÁ; Orrego JC; Coll Y; Karduss A; Rosenzweig S; Franco JL
    Biomedica; 2016 Jun; 36(2):204-12. PubMed ID: 27622481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term observational studies of chronic granulomatous disease.
    Kanariou M; Spanou K; Tantou S
    Curr Opin Hematol; 2018 Jan; 25(1):7-12. PubMed ID: 29135572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease.
    Brendel C; Rothe M; Santilli G; Charrier S; Stein S; Kunkel H; Abriss D; Müller-Kuller U; Gaspar B; Modlich U; Galy A; Schambach A; Thrasher AJ; Grez M
    Hum Gene Ther Clin Dev; 2018 Jun; 29(2):69-79. PubMed ID: 29664709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy for chronic granulomatous disease.
    Goebel WS; Dinauer MC
    Acta Haematol; 2003; 110(2-3):86-92. PubMed ID: 14583668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trial.
    Kang HJ; Bartholomae CC; Paruzynski A; Arens A; Kim S; Yu SS; Hong Y; Joo CW; Yoon NK; Rhim JW; Kim JG; Von Kalle C; Schmidt M; Kim S; Ahn HS
    Mol Ther; 2011 Nov; 19(11):2092-101. PubMed ID: 21878903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.